Literature DB >> 19811307

Lentiviral gene transfer of CTLA4 generates B cells with reduced costimulatory properties.

B Vogt1, M Warncke, B Micheel, A Sheriff.   

Abstract

Peripheral T-cell (TC) tolerance can be induced by tolerogenic antigen-presenting cell (APC). A prerequisite is the reduction or blockade of B7 of APC. Besides dendritic cell, B cells can be used as APC. Here, we show the generation B cells with reduced B7 expression by lentiviral transduction of endoplasmic reticulum (ER)-directed CTLA4. Vectors coding for the human CTL4-Ig were used for the human B-cell line Raji. Transduction efficiency was over 90% (MOI = 3). For the murine B-cell line A20 and for primary mouse B cells, murine CTLA4 was used. We show that B cells with reduced B7 expression reduce the antigen (Ag) specific TC proliferation in vitro. B cells expressing an ER-directed CTLA4 may reduce Ag-specific immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811307     DOI: 10.1080/08916930902832470

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  3 in total

1.  Insulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells.

Authors:  Xiao-Rui Geng; Gui Yang; Meng Li; Jiang-Ping Song; Zhi-Qiang Liu; Shuqi Qiu; Zhigang Liu; Ping-Chang Yang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

2.  Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.

Authors:  Maurizio Cutolo; Stefano Soldano; Paola Montagna; Amelia Chiara Trombetta; Paola Contini; Barbara Ruaro; Alberto Sulli; Stefano Scabini; Emanuela Stratta; Sabrina Paolino; Carmen Pizzorni; Vanessa Smith; Renata Brizzolara
Journal:  Arthritis Res Ther       Date:  2018-07-27       Impact factor: 5.156

3.  Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.

Authors:  Amit K Mittal; Nagendra K Chaturvedi; Rae A Rohlfsen; Payal Gupta; Avadhut D Joshi; Ganapati V Hegde; R Gregory Bociek; Shantaram S Joshi
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.